Literature DB >> 10862041

Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers.

S Nomoto1, N Haruki, Y Tatematsu, H Konishi, T Mitsudomi, T Takahashi, T Takahashi.   

Abstract

The short arm of chromosome 1 is among the most frequently affected regions in various types of common adult cancers as well as in neuroblastoma. In a previous study of ours, frequent allelic imbalance at the TP73 locus at 1p36 was noted in lung cancer despite the absence of TP73 mutations. This suggested the possible existence of an as yet unidentified tumor suppressor gene on 1p. Our initial attempt using the candidate gene approach did not yield any somatic mutations in the 14-3-3sigma gene (official gene symbol, SFN), a mediator of G2 arrest by TP53. Detailed deletion mapping of the telomeric region of 1p was thus carried out as an initial step toward positional cloning. We used seven polymorphic markers in addition to TP73 to examine 61 primary lung cancers. Allelic imbalance at one or more loci of 1p36 was observed in 30 of the 61 cases, whereas D1S508 at 1p36.2 exhibited the highest frequency (45%) of allelic imbalance among the 1p36 markers examined. In contrast, two proximal markers at 1p32-34 showed significantly less frequent (11-14%) allelic imbalance. Consequently, the present study identified the shortest region of overlap between D1S507 and TP73, which included the most frequently affected marker, D1S508. In addition, several cases exhibited allelic imbalance confined to a subtelomeric region distal to D1S2845 at 1p36.3. The present findings warrant future studies to identify the putative tumor suppressor gene(s) at 1p36 to gain a better understanding of the molecular pathogenesis of lung cancer. Genes Chromosomes Cancer 28:342-346, 2000. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10862041     DOI: 10.1002/1098-2264(200007)28:3<342::aid-gcc13>3.0.co;2-a

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  17 in total

1.  Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.

Authors:  D Astuti; F Latif; A Dallol; P L Dahia; F Douglas; E George; F Sköldberg; E S Husebye; C Eng; E R Maher
Journal:  Am J Hum Genet       Date:  2001-06-12       Impact factor: 11.025

Review 2.  The RUNX family: developmental regulators in cancer.

Authors:  Yoshiaki Ito; Suk-Chul Bae; Linda Shyue Huey Chuang
Journal:  Nat Rev Cancer       Date:  2015-01-16       Impact factor: 60.716

3.  EZH2 promotes cell proliferation by regulating the expression of RUNX3 in laryngeal carcinoma.

Authors:  Rong Lian; Huimin Ma; Zhiyan Wu; Guozheng Zhang; Lei Jiao; Wenjie Miao; Qianqian Jin; Ruixue Li; Ping Chen; Haixu Shi; Wenfa Yu
Journal:  Mol Cell Biochem       Date:  2017-08-09       Impact factor: 3.396

4.  Loss of heterozygosity on chromosome 1 in sporadic colorectal carcinoma.

Authors:  Chong-Zhi Zhou; Guo-Qiang Qiu; Fang Zhang; Lin He; Zhi-Hai Peng
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

5.  Upregulation of mitogen-inducible gene 6 triggers antitumor effect and attenuates progesterone resistance in endometrial carcinoma cells.

Authors:  W Xu; S Zhu; Y Zhou; Y Jin; H Dai; X Wang
Journal:  Cancer Gene Ther       Date:  2015-10-09       Impact factor: 5.987

6.  Association between RUNX3 promoter methylation and non-small cell lung cancer: a meta-analysis.

Authors:  Yali Liang; Lianping He; Hui Yuan; Yuelong Jin; Yingshui Yao
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

7.  Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.

Authors:  Yu-Wen Zhang; Ben Staal; Karl J Dykema; Kyle A Furge; George F Vande Woude
Journal:  PLoS One       Date:  2012-06-12       Impact factor: 3.240

8.  Genomic and gene expression profiling of minute alterations of chromosome arm 1p in small-cell lung carcinoma cells.

Authors:  L-J Henderson; B P Coe; E H L Lee; L Girard; A F Gazdar; J D Minna; S Lam; C MacAulay; W L Lam
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

9.  Expression of GITR Enhances Multiple Myeloma Cell Sensitivity to Bortezomib.

Authors:  Yinghao Zhao; Kun Zhang; Guangquan Li; Xingyi Zhang; Donglei Shi
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

10.  Novel tumor suppressor function of glucocorticoid-induced TNF receptor GITR in multiple myeloma.

Authors:  Yang Liu; Phong Quang; Esteban Braggio; Hai Ngo; Gayane Badalian-Very; Ludmila Flores; Yong Zhang; Antonio Sacco; Patricia Maiso; Abdel Kareem Azab; Feda Azab; Ruben Carrasco; Barrett J Rollins; Aldo M Roccaro; Irene M Ghobrial
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.